The invention provides improved agents and methods for treatment of
diseases associated with amyloid deposits of A.beta. in the brain of a
patient. Such methods entail administering agents that induce a
beneficial immunogenic response against the amyloid deposit. The methods
are useful for prophylactic and therapeutic treatment of Alzheimer's
disease. Preferred agents including N-terminal fragments of A.beta. and
antibodies binding to the same.
